Hired and retired: New appointments in the biopharma industry
Moderna, Novavax and Biogen are among the companies welcoming new faces to top jobs this month.
Archives for January 23, 2023
Charles River and Rznomics pair up on gene therapy development, Chinese CDMO lands $220m Series C funding
Charles River Laboratories International, Inc and Rznomics Inc, a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, have established a viral vector contract development and manufacturing...
Phesi: Long-term damage from COVID-19 movement restrictions on clinical development is becoming clearer
Phesi led analysis reveals an overall decrease in the number of recruiting trials and higher proportion of Phase 2 terminations in 2022.